Last reviewed · How we verify
SY-201 Ophthalmic Solution 0.5%
At a glance
| Generic name | SY-201 Ophthalmic Solution 0.5% |
|---|---|
| Sponsor | Seinda Pharmaceutical Guangzhou Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of SY-201 Ophthalmic Solution in Subjects With Dry Eye Disease (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |